Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981 Mar;19(3):461-4.
doi: 10.1128/AAC.19.3.461.

Pharmacokinetics of moxalactam in patients with renal insufficiency

Pharmacokinetics of moxalactam in patients with renal insufficiency

M Lam et al. Antimicrob Agents Chemother. 1981 Mar.

Abstract

Moxalactam pharmacokinetics were determined in 18 patients with renal insufficiency (creatinine clearance, 0 to 99 ml/min). Each patient was given 0.5 g of moxalactam intramuscularly. Drug half-life ranged from 4.1 to 49.1 h and correlated inversely with creatinine clearance (r = -0.97). Total body drug clearance ranged from 0 to 88 ml/min, and renal clearance ranged from 0 to 57 ml/min. In four patients studied during hemodialysis, drug half-life was 21.7 +/- 7.5 h (mean +/- standard error) between dialyses and 4.4 +/- 0.5 h during dialysis. Moxalactam dialysance averaged 44 +/- 2 ml/min per m2 of dialyzer surface area, and approximately 50% of the drug was removed during a single hemodialysis. We confirmed that moxalactam is eliminated from the body primarily by renal excretion. Recommendations are given for dosage adjustment in patients with renal insufficiency.

PubMed Disclaimer

References

    1. J Pharmacokinet Biopharm. 1973 Apr;1(2):137-63 - PubMed
    1. N Engl J Med. 1975 Nov 6;293(19):964-70 - PubMed
    1. J Pharm Sci. 1978 Dec;67(12):1687-91 - PubMed
    1. Antimicrob Agents Chemother. 1980 Feb;17(2):226-8 - PubMed
    1. Antimicrob Agents Chemother. 1980 Feb;17(2):273-9 - PubMed

LinkOut - more resources